0148 REACT study: A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients

The Breast ◽

10.1016/s0960-9776(09)70179-1 ◽

2009 ◽

Vol 18 ◽

pp. S56

Author(s):

G. von Minckwitz ◽

B. Conrad ◽

C. Denkert ◽

H. Eidtmann ◽

W. Eiermann ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Primary Breast Cancer ◽

Randomised Trial ◽

Phase Iii ◽

Breast Cancer Patients ◽

Double Blind ◽

React Study

Download Full-text

Abstract GS3-03: A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients (REACT – Randomised EuropeAn celecoxib trial)

10.1158/1538-7445.sabcs17-gs3-03 ◽

2018 ◽

Author(s):

RC Coombes ◽

H Tovey ◽

L Kilburn ◽

J Mansi ◽

C Palmieri ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Primary Breast Cancer ◽

Randomised Trial ◽

Phase Iii ◽

Breast Cancer Patients ◽

Double Blind

Download Full-text

A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients

http://isrctn.org/> ◽

10.1186/isrctn48254013 ◽

2013 ◽

Author(s):

R. Charles Coombes

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Primary Breast Cancer ◽

Randomised Trial ◽

Phase Iii ◽

Breast Cancer Patients ◽

Double Blind

Download Full-text

A phase III, multicenter, double-blind, randomized trial of celecoxib versus placebo in primary breast cancer patients: Randomized European Celecoxib Trial (REACT).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.tps115 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. TPS115-TPS115 ◽

Cited By ~ 2

Author(s):

R. C. Coombes ◽

G. Von Minckwitz ◽

J. Hicks ◽

P. Klare ◽

A. A. Evans ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Trial ◽

Cancer Patients ◽

Primary Breast Cancer ◽

Phase Iii ◽

Breast Cancer Patients ◽

Double Blind

Download Full-text

Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial

BMC Cancer ◽

10.1186/1471-2407-12-603 ◽

2012 ◽

Vol 12 (1) ◽

Cited By ~ 18

Author(s):

David Pérol ◽

Jocelyne Provençal ◽

Anne-claire Hardy-Bessard ◽

David Coeffic ◽

Jean-Phillipe Jacquin ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Early Breast Cancer ◽

Phase Iii ◽

Breast Cancer Patients ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo

Download Full-text

Mometasone Furoate Effect on Acute Skin Toxicity in Breast Cancer Patients Receiving Radiotherapy: A Phase III Double-Blind, Randomized Trial From the North Central Cancer Treatment Group N06C4

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2010.01.031 ◽

2011 ◽

Vol 79 (5) ◽

pp. 1460-1466 ◽

Cited By ~ 69

Author(s):

Robert C. Miller ◽

David J. Schwartz ◽

Jeff A. Sloan ◽

Patricia C. Griffin ◽

Richard L. Deming ◽

...

Keyword(s):

Breast Cancer ◽

Treatment Group ◽

Cancer Patients ◽

Skin Toxicity ◽

Phase Iii ◽

Breast Cancer Patients ◽

Double Blind ◽

North Central ◽

The North ◽

Acute Skin Toxicity

Download Full-text

A phase III randomised trial comparing the tolerability of dose-dense chemotherapy in older to that in younger breast cancer patients with four or more positive lymph nodes

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.589 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 589-589 ◽

Cited By ~ 3

Author(s):

S. Kuemmel ◽

J. Krocker ◽

A. Kohls ◽

M. Budner ◽

G.-P. Breitbach ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Nodes ◽

Cancer Patients ◽

Randomised Trial ◽

Phase Iii ◽

Breast Cancer Patients ◽

Dose Dense ◽

Positive Lymph Nodes

Download Full-text

A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil–epirubicine–cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000)

European Journal of Cancer ◽

10.1016/j.ejca.2013.09.023 ◽

2014 ◽

Vol 50 (1) ◽

pp. 23-30 ◽

Cited By ~ 4

Author(s):

C. Delbaldo ◽

D. Serin ◽

M. Mousseau ◽

S. Greget ◽

B. Audhuy ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Randomised Trial ◽

Phase Iii ◽

Breast Cancer Patients ◽

Node Positive ◽

Positive Breast Cancer

Download Full-text

Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy

Supportive Care in Cancer ◽

10.1007/s00520-014-2597-1 ◽

2015 ◽

Vol 23 (4) ◽

pp. 1137-1143 ◽

Cited By ~ 37

Author(s):

Yoshimasa Kosaka ◽

Yoshiaki Rai ◽

Norikazu Masuda ◽

Toshimi Takano ◽

Toshiaki Saeki ◽

...

Keyword(s):

Breast Cancer ◽

Febrile Neutropenia ◽

Randomized Trial ◽

Cancer Patients ◽

Phase Iii ◽

Breast Cancer Patients ◽

Double Blind

Download Full-text

A phase III randomised trial comparing the tolerability of dose-dense chemotherapy in older to that in younger breast cancer patients with four or more positive lymph nodes

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.589 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 589-589

Author(s):

S. Kuemmel ◽

J. Krocker ◽

A. Kohls ◽

M. Budner ◽

G.-P. Breitbach ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Nodes ◽

Cancer Patients ◽

Randomised Trial ◽

Phase Iii ◽

Breast Cancer Patients ◽

Dose Dense ◽

Positive Lymph Nodes

Download Full-text

Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide

European Journal of Cancer and Clinical Oncology ◽

10.1016/0277-5379(91)90311-z ◽

1991 ◽

Vol 27 (9) ◽

pp. 1137-1140 ◽

Cited By ~ 36

Author(s):

Norbert W. Marschner ◽

Matthias Adler ◽

Gerd A. Nagel ◽

Dietmar Christmann ◽

Edgar Fenzl ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Randomised Trial ◽

Advanced Breast ◽

Efficacy And Safety ◽

Breast Cancer Patients ◽

Double Blind ◽

Antiemetic Efficacy

Download Full-text